Cargando…
Healthcare resource use of patients with transthyretin amyloid cardiomyopathy
AIMS: Transthyretin amyloid cardiomyopathy (ATTR‐CM) is the cardiac manifestation of transthyretin amyloidosis (ATTR). The aim of this study was to estimate healthcare resource use for ATTR‐CM patients compared with heart failure (HF) patients, in Denmark, Finland, Norway, and Sweden. METHODS AND RE...
Autores principales: | Lauppe, Rosa, Liseth Hansen, Johan, Fornwall, Anna, Johansson, Katarina, Rozenbaum, Mark H., Strand, Anne Mette, Vakevainen, Merja, Kuusisto, Johanna, Gude, Einar, Smith, J. Gustav, Gustafsson, Finn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065857/ https://www.ncbi.nlm.nih.gov/pubmed/35365974 http://dx.doi.org/10.1002/ehf2.13913 |
Ejemplares similares
-
Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries
por: Lauppe, Rosa, et al.
Publicado: (2022) -
Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
por: Lauppe, Rosa Elisabeth, et al.
Publicado: (2021) -
Health‐related quality of life among transthyretin amyloid cardiomyopathy patients
por: Eldhagen, Per, et al.
Publicado: (2023) -
Suspicion, screening, and diagnosis of wild‐type transthyretin amyloid cardiomyopathy: a systematic literature review
por: Bay, Katrine, et al.
Publicado: (2022) -
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
por: Rozenbaum, Mark H., et al.
Publicado: (2022)